PORVAIR PLC

Report Publication Announcement • Apr 14, 2022

National Storage Mechanism | Additional information

RNS Number : 3412I

Porvair PLC

14 April 2022

For immediate release                                                                                                              14 April 2022

Porvair plc ("Porvair" or "The Group")

AGM Trading Update               

Porvair plc, the specialist filtration, laboratory and environmental technology group, will make the following trading statement today at its Annual General Meeting:

In the four months ended 31 March 2022, revenue growth was 14%, supported by the timing of the Kbio acquisition in February 2021.  Without acquisitions and at constant currency, revenue was up around 10%, with all three divisions showing growth. Near-term supply dislocations and inflationary pressures continue but the Group has avoided major problems thus far. Order books are in some cases flattered by extended lead times, but looked at on an underlying basis remain healthy.

The Group will announce its interim results for the six months ending 31 May 2022 on Monday 4 July 2022.

For more information, contact:

Porvair plc
Ben Stocks, Chief Executive	01553 765 500
James Mills, Group Finance Director	01553 765 500
Buchanan Communications	0207 466 5000
Charles Ryland / Steph Whitmore

Notes to Editors

Porvair is a group of specialist filtration, separation and environmental technologies businesses.  Its products are used in a range of niche filtration and separation markets, and are derived from its expertise in the design and manufacture of filtration and separation systems.  It is organised into three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCEANLDFAFAEFA